The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective

Saved in:
Bibliographic Details
Published in:Value in health 2014-11, Vol.17 (7), p.A343-A343
Main Authors: Charokopou, M, Vioix, H, Verheggen, B.G, Bratt, T, Franks, D
Format: Article
Language:English
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2014.08.689